Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept [7]

Rheumatology

Volumn 46, Issue 11, 2007, Pages 1741-1742

  Binymin, Khalid A ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b DGH Kew Southport   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; HEART ENZYME; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR;

ADULT ONSET STILL DISEASE; CARDIOMYOPATHY; HEART GRAFT; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MYOCARDITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REMISSION; SEROLOGY; VIRUS MYOCARDITIS;

ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; MYOCARDITIS; RECEPTORS, TUMOR NECROSIS FACTOR; STILL'S DISEASE, ADULT-ONSET; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35548995847     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem249     Document Type: Letter

References (13)

1. Kuek A, Weerakoon A, Ahmed K, Östör AJK. Adult-onset Still's disease and myocarditis: Successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology 2007;46:1043-4.
2. Fett JD. Viral particles in endomyocardial biopsy tissue from peripartum cardiomyopathy patients. Am J Obstet Gynecol 2006;195:330-1.
3. Kuhl U, Pauschinger M, Noutsias M et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with 'idiopatic' left ventricular dysfunction. Circulation 2005;111:887-93.
4. Dec GW Jr, Palacios IF, Fallon JT et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic Correlates, and clinical outcome. N Engl J Med 1985;312:885-90.
5. Cooper LT, Berry GJ, Shabetai R. Idiopatic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997;336:1860-6.
6. Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: Most fatal of autoimmune diseases. Semin Arthritis Rheum 2000;30:1-16.
7. Pulerwitz TC, Coppola TP, Felker GM et al. Mortality in primary and secondary myocarditis. Am Heart J 2004;147:46-50.
8. Kato S, Morimoto S, Hiramitsu S et al. Successful high-dose intravenous immunoglobulin therapy for a patient With fulminant myocarditis. Heart Vessels, 2007;22:48-51 Epub 26 January 2007.
9. McNamara DM, Starling RC, Dec GW. Intervention in myocarditis and acute cardiomyopathy with immune globulin: Results from the randomized placebo controlled IMAC trial. Circulation 1999;100(Suppl I):1211.
10. Robinson J, Hartling L, Vandermeer B, Crumley E, Klassen TP. Intravenous immunoglobulin für presumed viral myocarditis in children and adults. Cochrane Database of Systemic Reviews 2005. Art. No.: CD004370. DOI: 10.1002/14651858.CD004370.pub2.
11. Wada H, Saito K, Kanda T et al. Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyorcarditis in mice: A study using mice lacking TNF-alpha. Circulation 2001;103:743.
12. Caforio AL, Calabrese F, Angelini A et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenotic features at diagnosis. Eur Heart J 2007;28:1326-33Epub-9 May 2007.
13. Cunningham KS, Veinot JP, Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol 2006;59:121-9.